Prevalence of SARS-CoV-2 antibodies in healthy blood donors from the state of Tyrol, Austria, in summer 2020

被引：0
作者：
Anita Siller
Gregor A. Wachter
Sabrina Neururer
Bernhard Pfeifer
Manfred Astl
Wegene Borena
Janine Kimpel
Sebastian Elmer
Franziska Spöck
Anja Vales
Annelies Mühlbacher
Manfred Gaber
Peter Willeit
Harald Schennach
机构：
[1] Tirol Kliniken GmbH,Central Institute for Blood Transfusion and Immunology
[2] Tirol Kliniken GmbH,Department of Clinical Epidemiology, Tyrolean Federal Institute for Integrated Care
[3] UMIT—Private University for Health Sciences,Division for healthcare network and telehealth
[4] Medical Informatics and Technology GmbH,Institute for Virology, Department for Hygiene, Microbiology and Public Health
[5] Medical University of Innsbruck,Clinical Epidemiology Team
[6] Blood donor service Tyrol of the Austrian Red Cross,Department of Public Health and Primary Care
[7] Medical University of Innsbruck,undefined
[8] University of Cambridge,undefined
来源：
Wiener klinische Wochenschrift | 2021年 / 133卷
关键词：
Seropositivity; Covid-19; Epidemiology; Seroprevalence; Cross-sectional studies;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1272 / 1280
页数：8
相关论文
共 129 条
  • [1] Guan WJ(2020)Clinical Characteristics of Coronavirus Disease 2019 in China N Engl J Med 382 1708-1720
  • [2] Ni ZY(2020)Rapidly increasing cumulative incidence of coronavirus disease (COVID-19) Eurosurveillance 25 2000285-1016
  • [3] Hu Y(2021)High SARS-CoV-2 seroprevalence in children and adults in the Austrian ski resort of Ischgl Commun Med 1 4-661
  • [4] Liang WH(2020)Smell and taste dysfunction in patients with COVID-19 Lancet Infect Dis 20 1015-164
  • [5] Ou CQ(2020)COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study Lancet Child Adolesc Health 4 653-652
  • [6] He JX(2020)Age-Related Morbidity and Mortality among Patients with COVID-19 Infect Chemother 52 154-20
  • [7] Kinross P(2020)Emergence of coronavirus disease 2019 (COVID-19) in Austria Wien Klin Wochenschr. 132(21-22 645-1154
  • [8] Suetens C(2020)Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise Idaho J Clin Microbiol 58 e00941-1230
  • [9] Gomes Dias J(2021)Evaluation of four commercial, fully automated SARS-CoV‑2 antibody tests suggests a revision of the Siemens SARS-CoV‑2 IgG assay Clin Chem Lab Med 59 1143-782
  • [10] Alexakis L(2020)Comparison of Four SARS-CoV‑2 Neutralization Assays Vaccines 9 13-883
12345678910